Literature DB >> 14514669

Interaction between heme oxygenase-1 and -2 proteins.

Yi-Hao Weng1, Guang Yang, Sebastian Weiss, Phyllis A Dennery.   

Abstract

The three isoforms of heme oxygenase (HO), the rate-limiting enzyme in heme degradation, are the products of different genes that show marked differences in regulation and expression. Why is there redundancy in the heme degradation pathway, and why are there differences in tissue expression of HO isoenzymes are unanswered questions? An interaction between HO-1 and HO-2 is suspected by the co-localization of these enzymes in the lung and regions of the brain. Using multiple models and assays, we demonstrated an interaction between HO-1 and HO-2 at amino acids 0-45 of HO-2 and amino acids 58-80 of HO-1. The latter corresponds to a highly conserved, hydrophilic, and exposed region of the protein. Furthermore, the observed activity of the HO-1.HO-2 complex was lower than that expected from the sum of HO-1- and HO-2-derived activities, suggesting that this interaction serves to limit HO enzymatic activity. We speculate that this HO-1.HO-2 protein interaction may promote non-enzymatic functions of HO.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514669     DOI: 10.1074/jbc.M307644200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury.

Authors:  Luna Benvenisti-Zarom; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2007-03-24       Impact factor: 5.996

2.  Heme oxygenase-2/adiponectin protein-protein interaction in metabolic syndrome.

Authors:  Luca Vanella; Giovanni Li Volti; Salvatore Guccione; Giancarlo Rappazzo; Eliana Salvo; Morena Pappalardo; Stefano Forte; Michal L Schwartzman; Nader G Abraham
Journal:  Biochem Biophys Res Commun       Date:  2013-02-21       Impact factor: 3.575

3.  Heme oxygenase-2 deletion impairs macrophage function: implication in wound healing.

Authors:  Lars Bellner; Giuseppina Marrazzo; Nico van Rooijen; Michael W Dunn; Nader G Abraham; Michal L Schwartzman
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

4.  Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1.

Authors:  Zhen-Wei Xia; Li-Qing Xu; Wen-Wei Zhong; Jing-Jing Wei; Ning-Li Li; Jie Shao; Yun-Zhu Li; Shan-Chang Yu; Zi-Li Zhang
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

5.  Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response.

Authors:  Francesca Seta; Lars Bellner; Rita Rezzani; Raymond F Regan; Michael W Dunn; Nader G Abraham; Karsten Gronert; Michal Laniado-Schwartzman
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 6.  Signaling function of heme oxygenase proteins.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

7.  Heme oxygenase-1 regulates postnatal lung repair after hyperoxia: role of β-catenin/hnRNPK signaling.

Authors:  Guang Yang; Chhanda Biswasa; Qing Sara Lin; Ping La; Fumihiko Namba; Tiangang Zhuang; Manasa Muthu; Phyllis A Dennery
Journal:  Redox Biol       Date:  2013-02-08       Impact factor: 11.799

Review 8.  A review on hemeoxygenase-2: focus on cellular protection and oxygen response.

Authors:  Jorge Muñoz-Sánchez; María Elena Chánez-Cárdenas
Journal:  Oxid Med Cell Longev       Date:  2014-07-17       Impact factor: 6.543

9.  Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production.

Authors:  Sotiria Tzima; Panayiotis Victoratos; Ksanthi Kranidioti; Maria Alexiou; George Kollias
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

10.  Apo A1 Mimetic Rescues the Diabetic Phenotype of HO-2 Knockout Mice via an Increase in HO-1 Adiponectin and LKBI Signaling Pathway.

Authors:  Jian Cao; Nitin Puri; Komal Sodhi; Lars Bellner; Nader G Abraham; Attallah Kappas
Journal:  Int J Hypertens       Date:  2012-04-04       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.